Runx1 Foundation
- Assets
- $1.0m
- Revenue
- $1.5m
- Investments
- $0.0
- Employees
- 6
- Location
- Santa Barbara, CA
- Founding
- 05/2017
- Data as of
- 12/2023
- EIN
- 81-3557785
Organization Overview
Runx1 Foundation is located in Santa Barbara, CA. The organization was established in 2017. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. As of 12/2023, Runx1 Foundation employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Runx1 Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Runx1 Foundation generated $1.5m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 5 years, the organization has seen revenues fall by an average of (8.1%) each year. All expenses for the organization totaled $2.1m during the year ending 12/2023. As we would expect to see with falling revenues, expenses have declined by (0.6%) per year over the past 5 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2019, Runx1 Foundation has awarded 61 individual grants totaling $5,280,568. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
SEE SCHEDULE O.
Describe the Organization's Program Activity:
Part 3 - Line 4a
2023 INDEPENDENT GRANTS INCLUDE THE CONTINUED SUPPORT OF TWO RESEARCHERS AT UNIVERSITY OF PENNSYLVANIA: DR. NANCY SPECK ($175,000) IN THE OPTIMIZATION OF RUNX1-FPD CHIP MOUSE MODELS, AND DR. XIMENA JORDAN-BRUNO, BIOBANKING LEAD (60,000); AND ONGOING RESEARCH WITH DR. MORTY PONTZ AT CHILDRENS HOSPITAL OF PHILADELPHIA CHOP ($46,875)
SPONSORED RESEARCH. 2023 CO-FUNDING PARTNERSHIP WITH THE NATIONAL INSTITUTES OF HEALTH, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASE (NIAID) AND NATIONAL CANCER INSTITUTE (NCI), THIS GRANT MECHANISM SUPPORTS 2 PROJECTS WITH SCIENTIFIC INVESTIGATORS DR. ZON AND DR. CANTOR BOTH AT BOSTON CHILDRENS HOSPITAL AND THEIR COLLABORATORS AT NIAID AND NCI, RESPECTIVELY. THE TWO PROJECTS ARE ENTITLED, RESCUE OF RUNX1 DEFICIENCY PHENOTYPES IN RUNX1-FPD PATIENTS TREATED WITH IMATINI AND DEFINING CLONAL AND METABOLIC ALTERATIONS IN THE EVOLUTION OF RUNX1-FPD.
SPONSORED RESEARCH. 2023 CO-FUNDING PARTNERSHIP WITH ALEXS LEMONADE STAND FOUNDATION (ALSF) CONTINUED, $195,000 SUPPORTED A WIDE ARRAY OF GROUND BREAKING RESEARCH PROJECTS SPANNING BASIC SCIENCE HONING IN ON GENE REGULATORY NETWORKS AFFECTED BY RUNX1 MUTATIONS, CLASSIFICATION OF RUNX1 VARIANTS VIA NOVEL SATURATION MUTAGENESIS METHODS, MODELING CLONAL EVOLUTION DRIVEN BY COMMON SECONDARY SOMATIC MUTATIONS, DEVELOPMENT OF CLINICAL CONSENSUS GUIDELINES FOR RUNX1-FPD AND DEFINING THE ROLE OF NLRP3 INFLAMMASOME IN RUNX1 DEFICIENCY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Katrin Ericson President Executive Directo | OfficerTrustee | 40 | $428,910 |
Alex Gonzalez Director Of Development | 40 | $161,200 | |
Amanda Eggen Director Of Patient Engagemen | 40 | $141,308 | |
Timothy Babich Chairperson | OfficerTrustee | 15 | $0 |
Monica Babich Secretary Treasurer CFO | OfficerTrustee | 15 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $9,992 |
| All other contributions, gifts, grants, and similar amounts not included above | $1,532,831 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $1,542,823 |
| Total Program Service Revenue | $0 |
| Investment income | $6,189 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,549,012 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $815,318 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $428,910 |
| Compensation of current officers, directors, key employees. | $22,314 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $389,570 |
| Pension plan accruals and contributions | $47,801 |
| Other employee benefits | $59,455 |
| Payroll taxes | $45,434 |
| Fees for services: Management | $15,739 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $36,138 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $23,686 |
| Advertising and promotion | $12,249 |
| Office expenses | $25,182 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $55,245 |
| Travel | $17,125 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $4,683 |
| All other expenses | $93,211 |
| Total functional expenses | $2,069,746 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $157,941 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $869,068 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $4,218 |
| Total assets | $1,031,227 |
| Accounts payable and accrued expenses | $83,032 |
| Grants payable | $699,068 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $144,148 |
| Total liabilities | $926,248 |
| Net assets without donor restrictions | $104,979 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,031,227 |
Grants Awarded
Over the last fiscal year, Runx1 Foundation has awarded $815,318 in support to 11 organizations.
| Grant Recipient | Amount |
|---|---|
BOSTON CHILDRENS HOSPITAL PURPOSE: RiSE Grant Program | $250,000 |
UNIVERSITY OF WASHINGTON MEDICINE PURPOSE: Research in partnership with ALSF | $30,000 |
CHILDRENS HOSPITAL OF PHILADELPHIA PURPOSE: Independent RRP Grant | $46,875 |
DANA FARBER CANCER INSTITUTE PURPOSE: Research partnered with ALSF | $45,000 |
ALBERT EINSTEIN COLLEGE OF MEDICINE PURPOSE: Research partnered with ALSF | $30,000 |
MEMORIAL SLOAN KETTERING CANCER CTR PURPOSE: Research in partnership with ALSF | $30,000 |